ADH1C inhibits progression of colorectal cancer through the ADH1C/PHGDH /PSAT1/serine metabolic pathway
Sha Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Jinhua Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 67
Related Papers
CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
|Journal of Translational Medicine|2022|112
Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis
|Acta Pharmacologica Sinica|2022|77
Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis
|Oncology Reports|2018|50
Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
|Oncotarget|2017|44
Poly(ADP-ribose) Polymerase-1 Down-regulates BRCA2 Expression through the BRCA2 Promoter
|Journal of Biological Chemistry|2008|35